You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0263 Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – prognosis, predictors and outcome
AB0263 Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014400
Mar 2014600
Apr 2014200
May 20141804
Jun 2014100
Sep 2014501
Oct 2014300
Nov 2014400
Dec 2014300
Feb 2015200
Mar 2015200
Apr 2015401
Jul 2015500
Aug 2015300
Sep 2015400
Nov 2015600
Mar 2016200
Apr 2016200
May 2016300
Jun 2016300
Jul 2016400
Aug 2016400
Sep 2016200
Oct 2016200
Nov 2016300
Dec 2016500
Jan 2017400
Mar 2017300
Apr 2017600
May 2017200
Jun 2017200
Aug 20171000
Sep 2017400
Oct 2017400
Nov 2017400
Dec 2017400
Jan 20181000
Feb 2018200
Mar 2018400
Apr 2018600
May 20182001
Jun 2018400
Jul 2018800
Aug 2018600
Sep 2018200
Oct 2018200
Nov 2018400
Dec 2018400
Feb 2019200
Apr 2019200
May 2019200
Jul 2019200
Dec 2019200
Jun 2020400
Jul 2020600
Sep 2020800
Oct 2020101
Nov 2020300
Dec 2020400
Jan 2021400
Apr 2021400
May 2021100
Oct 2021600
Nov 2021401
Dec 2021400
Jan 2022600
Feb 2022700
Mar 2022500
May 20221000
Jun 2022200
Jul 20221400
Aug 2022400
Sep 2022400
Oct 2022400
Nov 2022600
Dec 2022600
Jan 20231600
Feb 20231000
Mar 2023200
May 2023400
Jul 2023200
Aug 2023601
Sep 2023600
Oct 2023200
Dec 20231200
Jan 2024200
Feb 2024600
Mar 2024400
Total416010